Skip to content

Effect of cupping on diabetes type II

Effect of wet cupping on blood gloucose, lipids and oxidative stress indices in patients with diabetes type II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013041513019N1
Enrollment
30
Registered
2013-05-20
Start date
2012-04-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus. Non-insulin-dependent diabetes mellitus

Interventions

Wet cupping (taking blood about 70 ml).
Treatment - Other
Wet cupping (taking blood about 70 ml)

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: No history of consumption of alcohol, Cigarette, Antioxidant; No suffering from special diseases like Cancer, Thyroid gland disorders, Cardiovascular diseases, Respiratory diseases, Anemia, Coagulation disorders; Menopause period; Exclusion criteria: Creatinine above 2.5; Hemoglobin below 10 mg/dl; Vitamins and complements consumption; carbohydrates consumption;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1C. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.;Fasting Blood Sudar. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.;Blood sugar 2 hours after fasting. Timepoint: Before & After treatment. Method of measurement: Eliza with Pars Azmon Kit.

Secondary

MeasureTime frame
Triglycerid. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Cholesterol. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Low Density Lipoprotein. Timepoint: Before & after treatment. Method of measurement: Eliza with Pars Azmon Kit.;Lipid peroxidation. Timepoint: Before & after treatment. Method of measurement: TBA (Thio Barbituric Acid).;Serum total Antioxidants. Timepoint: Before and after. Method of measurement: FRAP test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.ahmad Akbari

Arak University of Medical Sciences

dr.akbari49@yahoo.com+98 614173528

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026